News Novartis' LEE011 on fast track to challenge Ibrance US regulator grants fast review for breast cancer drug.
News GSK settles US bribery probe for $20m Actions of Chinese subsidiaries violated US bribery laws, says SEC.
Views & Analysis Astellas wins first Real-World Evidence prize at UK awards UK awards first to introduce a real-world evidence category.
News Pfizer's breast cancer drug step closer to EU approval Ibrance is already Pfizer's top oncology product.
News Novartis/Amgen migraine drug shows promise Mid-stage data suggests drug reduces monthly migraine days.
Patients Biosimilars & patient access independent of geographies or s... Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
